Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Previous years symbols : SRDX save search
In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
QGEN | $39.32 -0.88% 0.0% 740K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
DHR | $240.34 0.28% 0.0% 3.2M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
BIO | $292.75 -2.55% 0.0% 200K
|
Health Technology
|
| O: 0.62%
H: 2.18%
C: 2.02%
BDX | $231.01 -1.58% 0.0% 1.1M
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.34%
A | $136.8 -2.44% 0.0% 1.3M
|
Health Technology
|
| O: 0.86%
H: 1.26%
C: 1.18%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.99%
H: 2.11%
C: 1.09%
QGEN | $39.32 -0.88% 0.0% 740K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
ILMN | $117.66 -2.89% -2.97% 1.7M
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
HOLX | $75.1 -3.15% -3.25% 1.8M
|
Health Technology
|
| O: 0.56%
H: 1.01%
C: 0.98%
AXDX M | $0.82 -9.89% -10.98% 45K
|
Health Technology
|
| O: 4.13%
H: 1.0%
C: 1.0%
diagnostics market
Surmodics to Participate in Upcoming Investor Conferences in March and April
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 1.24%
H: 0.54%
C: -0.39%
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
Published: 2024-02-01 (Crawled : 14:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: -3.72%
H: 9.88%
C: -4.34%
first year financial
Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight
Published: 2024-01-24 (Crawled : 22:00) - prnewswire.com
TRUMF | $16.504 -17.59% 1.7K
|
Health Technology
|
| O: 3.54%
H: 0.0%
C: 0.0%
TRUMY | $16.53 0.79% 31K
|
Manufacturing
|
| O: -0.3%
H: 0.18%
C: -0.06%
PHG | $20.33 -0.39% 0.0% 740K
|
Health Technology
|
| O: 0.0%
H: 0.57%
C: 0.48%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -1.0%
H: 0.84%
C: 0.04%
BSX | $68.12 1.01% 0.02% 6.6M
|
Health Technology
|
| O: 0.58%
H: 0.98%
C: 0.93%
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: -1.34%
expected global growth market
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
Published: 2024-01-22 (Crawled : 13:30) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: -0.18%
H: 1.92%
C: -0.8%
removal
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
Published: 2024-01-16 (Crawled : 14:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: -1.3%
H: 1.02%
C: 0.63%
first report financial results
Surmodics to Host Virtual Annual Meeting of Shareholders - January 16, 2024
Published: 2024-01-16 (Crawled : 14:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: -1.3%
H: 1.02%
C: 0.63%
meeting
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
Published: 2023-11-16 (Crawled : 15:30) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.0%
H: 1.21%
C: 0.62%
trial
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28
Published: 2023-11-14 (Crawled : 00:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 4.02%
H: 2.91%
C: 2.91%
conference
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 4.97%
H: 5.2%
C: 2.28%
year financial
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
Published: 2023-11-07 (Crawled : 13:00) - biospace.com/
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.69%
H: 1.71%
C: 0.95%
symposium trial transcend
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
Published: 2023-11-07 (Crawled : 13:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.69%
H: 1.71%
C: 0.95%
symposium trial
Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications
Published: 2023-10-31 (Crawled : 00:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.55%
H: 1.75%
C: 1.24%
device durability medical
Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8
Published: 2023-10-10 (Crawled : 12:30) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.38%
H: 1.87%
C: 0.66%
report financial results
Coatings for Medical Devices Market Set to Double: Projected to Reach $21.7 Billion by 2030 with an 8.5% CAGR
Published: 2023-08-23 (Crawled : 15:00) - prnewswire.com
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.21%
H: 1.09%
C: -0.99%
reach set medical market
MCRA Aids Surmodics in Obtaining FDA Pre-Market Approval for Cardiovascular Drug-Coated Balloon
Published: 2023-08-07 (Crawled : 15:00) - prnewswire.com
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.59%
H: 3.16%
C: 1.61%
fda approval cardiovascular
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
Published: 2023-06-27 (Crawled : 12:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.56%
H: 0.13%
C: -0.86%
KRMD | $2.16 3.85% 3.7% 98K
|
Health Technology
|
| O: 0.83%
H: 4.66%
C: -1.37%
medical financial
Biocompatible Coatings Market worth $29.7 billion by 2028 - Exclusive Report by MarketsandMarkets™
Published: 2023-06-22 (Crawled : 08:00) - prnewswire.com
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: -0.17%
H: 4.16%
C: 3.56%
report market
Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon
Published: 2023-06-20 (Crawled : 12:00) - biospace.com/
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 3.71%
H: 12.69%
C: 11.96%
fda approval
Global Hydrophilic Coating Market Report 2023: Technological Advancements in Hydrophilic Coatings Drives Growth
Published: 2023-06-14 (Crawled : 23:00) - prnewswire.com
SRDX | $26.61 0.72% 0.71% 160K
|
Health Technology
|
| O: 0.0%
H: 1.2%
C: -1.32%
report global growth market
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.